Published in Cardiovasc Hematol Agents Med Chem on January 01, 2007
The immune system and cardiac repair. Pharmacol Res (2008) 3.42
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension (2011) 1.79
Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol (2008) 1.69
Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc Ther (2010) 1.39
Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32
Rapid recruitment of temporally distinct vascular gene sets by estrogen. Mol Endocrinol (2008) 1.16
Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload. FASEB J (2012) 1.09
Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine (Lond) (2008) 1.04
TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival. PLoS One (2008) 0.99
The interaction of Thrombospondins with extracellular matrix proteins. J Cell Commun Signal (2009) 0.97
Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension. J Cardiothorac Surg (2010) 0.97
Thrombospondins in the heart: potential functions in cardiac remodeling. J Cell Commun Signal (2009) 0.93
Localization of thrombospondin-1 and myofibroblasts during corneal wound repair. Exp Eye Res (2011) 0.92
Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol (2014) 0.92
Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics (2010) 0.90
Matrix metalloproteinases: drug targets for myocardial infarction. Curr Drug Targets (2013) 0.84
Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. Proteomics Clin Appl (2013) 0.83
Thrombospondins: old players, new games. Curr Opin Lipidol (2013) 0.80
Age and diet affect gene expression profiles in canine liver tissue. PLoS One (2010) 0.78
Proangiogenic Properties of Thrombospondin-4. Arterioscler Thromb Vasc Biol (2015) 0.77
Thrombospondins in the transition from myocardial infarction to heart failure. J Mol Cell Cardiol (2015) 0.77
Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy. Exp Ther Med (2016) 0.76
Association of serum periostin with cardiac function and short-term prognosis in acute myocardial infarction patients. PLoS One (2014) 0.75
Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment. Int J Mol Sci (2017) 0.75
Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers. Cell Death Discov (2015) 0.75
Differential expression of pancreatitis-associated protein and thrombospondins in arterial versus venous tissues. J Vasc Res (2009) 0.75
Thrombospondins: A Role in Cardiovascular Disease. Int J Mol Sci (2017) 0.75
The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res (2006) 4.38
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res (2005) 4.14
Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science (2004) 3.66
Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation (2007) 3.07
Potential risks of bone marrow cell transplantation into infarcted hearts. Blood (2007) 2.97
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A (2006) 2.85
The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol (2009) 2.80
Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol (2004) 2.61
TGF-β signaling in fibrosis. Growth Factors (2011) 2.42
Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res (2009) 2.38
Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol (2010) 2.35
Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen (2009) 2.33
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation (2007) 2.14
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation (2005) 2.09
Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab (2003) 2.01
Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol (2008) 1.97
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res (2010) 1.94
Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol (2008) 1.90
Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci (2004) 1.80
Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension (2011) 1.79
A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. EMBO J (2003) 1.72
CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol (2010) 1.69
Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol (2004) 1.69
Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res (2013) 1.61
Aging and Cardiac Fibrosis. Aging Dis (2011) 1.58
Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy (2003) 1.53
The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol (2006) 1.52
CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol (2008) 1.51
Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci U S A (2003) 1.50
Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A (2008) 1.48
MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proc Natl Acad Sci U S A (2002) 1.47
Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. J Biol Chem (2003) 1.46
Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol (2013) 1.46
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol (2008) 1.45
The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz) (2009) 1.45
c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J (2003) 1.42
Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem (2002) 1.41
Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta (2012) 1.41
Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol (2002) 1.38
The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res (2009) 1.37
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35
The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev (2010) 1.30
Butylhydroquinone protects cells genetically deficient in glutathione biosynthesis from arsenite-induced apoptosis without significantly changing their prooxidant status. Toxicol Sci (2005) 1.29
Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res (2009) 1.28
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol (2006) 1.27
Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem (2005) 1.26
Electroacupuncture increased cerebral blood flow and reduced ischemic brain injury: dependence on stimulation intensity and frequency. J Appl Physiol (1985) (2011) 1.23
Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact (2002) 1.23
Active interstitial remodeling: an important process in the hibernating human myocardium. J Am Coll Cardiol (2002) 1.22
The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell (2008) 1.21
Cellular cardiomyoplasty improves survival after myocardial injury. Circulation (2002) 1.21
MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am J Physiol Heart Circ Physiol (2003) 1.20
MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol (2005) 1.20
Focus on molecules: lumican. Exp Eye Res (2005) 1.19
Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol (2002) 1.19
Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it? Prog Neurobiol (2009) 1.18
Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem Pharmacol (2002) 1.17
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets (2007) 1.16
Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation (2003) 1.14
IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol (2013) 1.14
c-Jun, at the crossroad of the signaling network. Protein Cell (2011) 1.14
Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol (2012) 1.12
Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest (2013) 1.10
Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol (2002) 1.09
Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation (2002) 1.09
Current research on opioid receptor function. Curr Drug Targets (2012) 1.07
Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer. Chin Med J (Engl) (2011) 1.07
Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J Histochem Cytochem (2013) 1.06
delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia. J Cell Physiol (2007) 1.05
Impact of myocardial structure and function postinfarction on diastolic strain measurements: implications for assessment of myocardial viability. Am J Physiol Heart Circ Physiol (2005) 1.05
A critical role for IkappaB kinase beta in metallothionein-1 expression and protection against arsenic toxicity. J Biol Chem (2007) 1.05
Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2. Development (2007) 1.04
A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing. Mol Biol Cell (2006) 1.04
Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke (2006) 1.04
Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol (2012) 1.02
The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells. Stem Cells Dev (2011) 1.02
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol (2005) 1.01
The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res (2012) 1.01
IκB kinase β regulates epithelium migration during corneal wound healing. PLoS One (2011) 1.00
delta-Opioid receptor activation attenuates oxidative injury in the ischemic rat brain. BMC Biol (2009) 1.00
Primary involvement of NADPH oxidase 4 in hypoxia-induced generation of reactive oxygen species in adipose-derived stem cells. Stem Cells Dev (2012) 1.00
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res (2006) 1.00